These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 12410647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
    Antovic JP, Antovic A.
    Thromb Haemost; 2003 Oct; 90(4):620-7. PubMed ID: 14515182
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.
    Lisman T, Mosnier LO, Lambert T, Mauser-Bunschoten EP, Meijers JC, Nieuwenhuis HK, de Groot PG.
    Blood; 2002 Jan 01; 99(1):175-9. PubMed ID: 11756168
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
    Taketomi T, Szlam F, Bader SO, Sheppard CA, Levy JH, Tanaka KA.
    Blood Coagul Fibrinolysis; 2008 Mar 01; 19(2):135-41. PubMed ID: 18277134
    [Abstract] [Full Text] [Related]

  • 5. Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A.
    Lisman T, de Groot PG, Lambert T, Røjkjaer R, Persson E.
    J Thromb Haemost; 2003 Oct 01; 1(10):2175-8. PubMed ID: 14521601
    [Abstract] [Full Text] [Related]

  • 6. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
    Antovic JP, Rafik Hamad R, Antovic A, Blombäck M, Bremme K.
    Thromb Haemost; 2002 Oct 01; 88(4):644-7. PubMed ID: 12362237
    [Abstract] [Full Text] [Related]

  • 7. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb 01; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 8. Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.
    Bakhtiari K, Kamphuisen PW, Mancuso ME, Hamulyak K, Schutgens RE, Santagostino E, Meijers JC.
    Br J Haematol; 2013 Sep 01; 162(6):827-35. PubMed ID: 23889493
    [Abstract] [Full Text] [Related]

  • 9. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D, Szlam F, Molinaro RJ, Escobar MA, Levy JH, Tanaka KA.
    Haemophilia; 2010 May 01; 16(3):510-7. PubMed ID: 20050927
    [Abstract] [Full Text] [Related]

  • 10. General haemostatic agents--fact or fiction?
    Hedner U.
    Pathophysiol Haemost Thromb; 2002 May 01; 32 Suppl 1():33-6. PubMed ID: 12214145
    [Abstract] [Full Text] [Related]

  • 11. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct 01; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 12. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F, Carrieri C, Galasso R, Scaraggi FA, Di Serio F, Woodhams B, Semeraro N, Colucci M.
    J Thromb Haemost; 2013 Feb 01; 11(2):315-24. PubMed ID: 23256818
    [Abstract] [Full Text] [Related]

  • 13. FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based models.
    Ammollo CT, Semeraro F, Vitulli A, Dirienzo L, Mezzasoma AM, Semeraro N, Gresele P, Colucci M.
    Haemophilia; 2020 Jul 01; 26(4):e151-e160. PubMed ID: 32325538
    [Abstract] [Full Text] [Related]

  • 14. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K, Nakatomi Y, Araki T, Teshima K, Nakano H, Nakagaki T, Miyamoto S, Funatsu A, Iwanaga S.
    Vox Sang; 2003 Nov 01; 85(4):290-9. PubMed ID: 14633255
    [Abstract] [Full Text] [Related]

  • 15. Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.
    Antovic J, Schulman S, Eelde A, Blombäck M.
    Haemophilia; 2001 Nov 01; 7(6):557-60. PubMed ID: 11851753
    [Abstract] [Full Text] [Related]

  • 16. On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.
    Mikovic D, Woodhams BJ, Holmström M, Elezovic I, Antovic A, Mobarrez F, Elfvinge P, Antovic JP.
    Int J Lab Hematol; 2012 Feb 01; 34(1):35-40. PubMed ID: 21707936
    [Abstract] [Full Text] [Related]

  • 17. Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.
    Gray LD, Hussey MA, Larson BM, Machlus KR, Campbell RA, Koch G, Ezban M, Hedner U, Wolberg AS.
    Thromb Res; 2011 Dec 01; 128(6):570-6. PubMed ID: 21561645
    [Abstract] [Full Text] [Related]

  • 18. Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.
    Antovic JP, Yngen M, Ostenson CG, Antovic A, Wallen HN, Jorneskög G, Blombäck M.
    Blood Coagul Fibrinolysis; 2003 Sep 01; 14(6):551-6. PubMed ID: 12960608
    [Abstract] [Full Text] [Related]

  • 19. Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor.
    Foley JH, Nesheim ME.
    J Thromb Haemost; 2009 Mar 01; 7(3):453-9. PubMed ID: 19087221
    [Abstract] [Full Text] [Related]

  • 20. Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.
    Antovic A, Mikovic D, Elezovic I, Zabczyk M, Hutenby K, Antovic JP.
    Thromb Haemost; 2014 Apr 01; 111(4):656-61. PubMed ID: 24258360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.